• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Chlorhexidine bathing significantly reduces the development of hospital-acquired blood-stream infections

bys25qthea
February 6, 2013
in Infectious Disease
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

Feb 6th – NEJM – Daily bathing with a chlorhexidine-impregnated washcloth was associated with a 28% lower rate of bloodstream infections. 

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. Daily bathing with a chlorhexidine-impregnated washcloth was associated with a 28% lower rate of bloodstream infections when compared with daily washing with a nonantimicrobial washcloth.

2. Chlorhexidine bathing was also associated with a 25% reduction in acquisition of multidrug-resistant organisms.

This randomized study examined the effect of chlorhexidine washes on incidence of infection and development of multidrug-resistant organisms in ICUs and bone marrow transplant units.  The authors found that replacing standard daily washes with washes using a chlorhexidine-impregnated washcloth significantly lowered the incidence of blood-stream infections and the acquisition of the drug resistant organisms MRSA and VRE.  Of note, during the study the company providing the chlorhexidine washcloths temporarily recalled them due to a Burkholderia cepacia contamination of some of the lots.  Patients were immediately switched to the nonantimicrobial washcloths, and data from the centers were omitted from analysis of the chlorhexidine treatment.  Additionally, two units were eliminated from the analysis due to low compliance with the study protocol.  Overall, the results suggest that a low-cost, straightforward intervention could significantly lower the incidence of hospital-acquired infections and acquisition of drug-resistant organisms.

RELATED REPORTS

Cervical intraepithelial neoplasia grade 3 associated with adverse pregnancy outcomes

#VisualAbstract: Rates of surgical site infections are similar between chlorhexidine and iodine-based skin preparations

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

Click to read the study in NEJM

[/tab]

[tab]

Image: PD

1. Daily bathing with a chlorhexidine-impregnated washcloth was associated with a 28% lower rate of bloodstream infections when compared with daily washing with a nonantimicrobial washcloth.

2. Chlorhexidine bathing was also associated with a 25% reduction in acquisition of multidrug-resistant organisms.

This [cluster-randomized crossover] study: collected data from multiple centers between 2007 and 2009.  Units were assigned to bathe patients daily using either washcloths with 2% chlorhexidine gluconate or a nonantimicrobial washcloth for six months.  The centers then would switch and use the alternative product for a second six month period.  Patients were then monitored for MRSA and VRE colonization as well as blood stream infections.  165 new cases of MRSA or VRE developed during control periods, while only 127 developed during the chlorhexidine wash periods, yielding a 28% lower rate.  However, there was no significant difference in the rates of MRSA or VRE bacteremia.  Additionally ICUs showed a 40% lower rate of bloodstream infections with chlorhexidine bathing.  Other units showed a 17% lower rate.  There were no skin reactions attributed to chlorhexidine.

In sum: This randomized study examined the effect of chlorhexidine washes on incidence of infection and development of multidrug-resistant organisms in ICUs and bone marrow transplant units.  The authors found that replacing standard daily washes with washes using a chlorhexidine-impregnated washcloth significantly lowered the incidence of blood-stream infections and the acquisition of the drug resistant organisms MRSA and VRE.  Of note, during the study the company providing the chlorhexidine washcloths temporarily recalled them due to a Burkholderia cepacia contamination of some of the lots.  Patients were immediately switched to the nonantimicrobial washcloths, and data from the centers were omitted from analysis of the chlorhexidine treatment.  Additionally, two units were eliminated from the analysis due to low compliance with the study protocol.  Overall, the results suggest that a low-cost, straightforward intervention could significantly lower the incidence of hospital-acquired infections and acquisition of drug-resistant organisms.

Click to read the study in NEJM

By Akira Shishido and Mitalee Patil

More from this author: Pneumocystis linked to sudden infant deaths, Continuous infusion of beta-lactams may be superior to bolus therapy, Novel antiviral drug reduces influenza viral load, Three months of antibiotics appear to effectively treat early-onset spinal implant infections, [Physician Comment] Recurrent early Lyme disease is caused by reinfection, not relapse, Hospital Acquired MRSA pays no attention to vancomycin effectiveness, Oseltamivir treats avian flu early, Linezolid treats Chronic Extensively Drug-Resistant TB but has a high incidence of adverse effects, Intermittent and continuous antiretroviral therapies are equivalent in the treatment of acute HIV-1 infection, Peginesatide is noninferior to epoetin for anemia in hemodialysis patients [EMERALD Trials], Antibiotics improve outcomes in severe acute malnutrition

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

[/tab]

[/tabs]

Tags: Chlorhexidineinfection
Previous Post

Pre-operative discussion of analgesic goals improves pediatric post-operative pain management

Next Post

Intravenous omeprazole after endoscopy reduces rebleeding in patients with peptic ulcers [Classics Series]

RelatedReports

5-FU a promising treatment for CIN-2
Chronic Disease

Cervical intraepithelial neoplasia grade 3 associated with adverse pregnancy outcomes

February 22, 2022
#VisualAbstract: Rates of surgical site infections are similar between chlorhexidine and iodine-based skin preparations
StudyGraphics

#VisualAbstract: Rates of surgical site infections are similar between chlorhexidine and iodine-based skin preparations

January 6, 2022
#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma
StudyGraphics

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

December 31, 2021
Ultrasound enhances gastrointestinal absorption of drugs at low frequencies
Wellness

Wellness Check: Addictions

December 23, 2021
Next Post

Intravenous omeprazole after endoscopy reduces rebleeding in patients with peptic ulcers [Classics Series]

Study hints at causal link between lipoprotein(a) and calcific aortic stenosis

Surgical crisis checklists improve performance during operating-room crisis simulations

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma
  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
  • Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.